Barclays Maintains an 'Underweight' on Omnicare (OCR); June Quarter Review - After the Call
Tweet Send to a Friend
Barclays maintains an 'Underweight' on Omnicare (NYSE: OCR) price target of $32.00.
Barclays analyst says, "We continue to believe the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "We continue to believe the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
